A drug given to early stage lung cancer patients before they undergo surgery showed major tumor responses in the removed tumor and an increase in anti-tumor T-cells that remained after the tumor was removed, which resulted in fewer relapse cases in the patients.
https://ift.tt/2vj5UFw
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου